Assessment of Etest as an Alternative to Agar Dilution for Antimicrobial Susceptibility Testing of Neisseria gonorrhoeae
Authors:
Open Access
- 1 May 2014
- journal article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 52 (5) , 1435-1440
Abstract
We studied whether the Etest can be used as an alternative to agar dilution to determine antimicrobial susceptibilities of ceftriaxone, cefixime, and cefpodoxime inNeisseria gonorrhoeaesurveillance. One hundred fifteen clinical and laboratory isolates ofN. gonorrhoeaewere tested following the Clinical Laboratory Improvement Amendments (CLIA)-approved CLSI standard agar dilution method and, separately, by the Etest according to the manufacturer's recommendations. The MICs were determined and compared. Ten laboratory-generated mutants were used to simulate substantially nonsusceptible specimens. The Etest and agar dilution methods were well correlated. Statistical tests produced regressionR2values of 88%, 82%, and 85% and Pearson correlation coefficients of 92%, 91%, and 92% for ceftriaxone, cefixime, and cefpodoxime, respectively. When paired comparisons were made, the two tests were 88.7%, 80%, and 87% within 1 log2dilution from each other for ceftriaxone, cefixime, and cefpodoxime, respectively. The within-2-log2agreements were 99.1%, 98.3%, and 94.8% for ceftriaxone, cefixime, and cefpodoxime, respectively. Notwithstanding the good correlations and the within-2-log2general agreement, the Etest results produced slightly lower MICs than the agar dilution results. In conclusion, we found that the Etest can be effectively used as an alternative to agar dilution testing to determine the susceptibility ofN. gonorrhoeaeto ceftriaxone, cefixime, and cefpodoxime, although we recommend further research into extremely resistant isolates. For isolates within the typical range of clinical MICs, reexamination of the Etest interpretation of susceptible and nonsusceptible categories would likely allow for successful transition from agar dilution to the Etest.Keywords
This publication has 17 references indexed in Scilit:
- Update to CDC's Sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections.2012
- Comparative assessment of CDS, CLSI disc diffusion and Etest techniques for antimicrobial susceptibility testing ofNeisseria gonorrhoeae: a 6-year studyBMJ Open, 2012
- Cephalosporin susceptibility among Neisseria gonorrhoeae isolates--United States, 2000-2010.2011
- Cephalosporin MIC creep among gonococci: time for a pharmacodynamic rethink?Journal of Antimicrobial Chemotherapy, 2010
- Cost analysis and antimicrobial susceptibility testing comparing the E test and the agar dilution method in Campylobacter jejuni and Campylobacter coliDiagnostic Microbiology and Infectious Disease, 2009
- Meeting the public health challenge of multidrug- and extensively drug-resistantNeisseria gonorrhoeaeExpert Review of Anti-infective Therapy, 2009
- The use of cephalosporins for gonorrhea: the impending problem of resistanceExpert Opinion on Pharmacotherapy, 2009
- Treatment of uncomplicated gonococcal urethritis by double-dosing of 200 mg cefixime at a 6-h intervalJournal of Infection and Chemotherapy, 2003
- Trends in Resistance of Neisseria gonorrhoeae to Antimicrobial Agents in the United StatesSexually Transmitted Diseases, 1988
- Effect of Spectinomycin Use on the Prevalence of Spectinomycin-Resistant and of Penicillinase-ProducingNeisseria GonorrhoeaeNew England Journal of Medicine, 1987